Interaction with the pharmacokinetics of ethinylestradiol and progestogens contained in oral contraceptives
- 1 September 1989
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 40 (3) , 299-312
- https://doi.org/10.1016/0010-7824(89)90094-2
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Effect of two oral contraceptives containing 30 μg ethinylestradiol and 75 μg gestodene or 150 μg desogestrel upon various hormonal parametersContraception, 1988
- Alterations in the serum levels of gestodene and SHBG during 12 cycles of treatment with 30 μg ethinylestradiol and 75 μg gestodeneContraception, 1988
- Serum levels of 3-keto-desogestrel and SHBG during 12 cycles of treatment with 30 μg ethinylestradiol and 150 μg desogestrelContraception, 1988
- Clinical Pharmacokinetics of Oral Contraceptive SteroidsClinical Pharmacokinetics, 1983
- Plasma levels of ethinylestradiol (EE) during cyclic treatment with combined oral contraceptivesContraception, 1981
- Variation of Ethinylestradiol Blood Levels Among Healthy Women Using Oral ContraceptivesFertility and Sterility, 1980
- Plasma levels and pharmacokinetics of ethynyl estrogens in various populationsContraception, 1980
- Rate of metabolism of norethisterone in women from different populationsContraception, 1979
- Evidence of Higher Ethynylestradiol Blood Levels in Human Hypertensive Oral Contraceptive UsersFertility and Sterility, 1977
- Serum Drug Concentrations as Therapeutic GuidesNew England Journal of Medicine, 1972